Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Das-Gupta E, Greinix H, Jacobs R, Zhou L, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Jagasia M (2014) Haematologica 99: 1746-52 Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, Chen H, Chinratanalab W, Goodman S, Greer JP, Schuening F (2009) Biol Blood Marrow Transplant 15: 1288-95 Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Sengsayadeth SM, Srivastava S, Jagasia M, Savani BN (2012) Biol Blood Marrow Transplant 18: 1479-87 Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis. Jagasia M, Greinix H, Robin M, Das-Gupta E, Jacobs R, Savani BN, Engelhardt BG, Kassim A, Worel N, Knobler R, Russell N, Socie G (2013) Biol Blood Marrow Transplant 19: 1129-33 Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Lucid CE, Savani BN, Engelhardt BG, Shah P, Clifton C, Greenhut SL, Vaughan LA, Kassim A, Schuening F, Jagasia M (2011) Bone Marrow Transplant 46: 426-9 Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma. McGirt LY, Baerenwald DA, Vonderheid EC, Eischen CM (2015) J Eur Acad Dermatol Venereol 29: 2269-71
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.